Pharma & Bio
Lifestyle
'U.S. Government Streamlines Clinical Trial Plans and Phase 1 Procedures'... Celltrion Gains Momentum for 20 New Drugs
Celltrion(068270)is expected to further accelerate its global new drug development efforts, buoyed by the U.S. health authorities’ sudden policy shift toward clinical development innovation. At a time…
Lifestyle
Embolization Techniques: Shift from Permanent to Temporary Occlusion... NextBio’s Value Set to Rise
The paradigm in the embolization (a procedure that treats lesions by blocking blood vessels) market is shifting. The medical community appears to be shifting away from the traditional approach of perm…
Technology
'From FDA Approval to Phase 3 Topline Results'… What Are the Major K-Bio Events to Watch in the Second Half of the Year?
As capital flowed into semiconductor and artificial intelligence (AI) companies, domestic pharmaceutical and biotech firms were relatively sidelined in the first half of this year. Although quite a fe…
Lifestyle
[BioUSA] Fred Kim, U.S. Branch Manager of AriBio: “Fushing Pharmaceutical Is Also Interested in Other Pipeline Projects... Potential for Further Collaboration”
At the BioUSA event held in San Diego, USA, until just last year, #AriBio had to actively seek out global pharmaceutical companies and investors to introduce the company and request meetings. However,…
Lifestyle
Boehringer Ingelheim Considers Direct Investment in K-Bio... “Discussions Underway for Follow-On Investments in Korean Companies” [only-EDAILY]
Global pharmaceutical giant Boehringer Ingelheim is expected to expand its investments in and technology acquisitions from Korean biotech companies through its venture fund. In particular, it has been…
Technology
BIODYNE CO., LTD.’s ‘EarlyPop’ Passes EU MDR Conformity Assessment… Shipments to Russia and Vietnam Imminent
Earlypap®, a self-collection brush for cervical cancer screening developed by BIODYNE CO., LTD.(314930), has passed the European Medical Device Regulation (MDR) conformity assessment, bringing the com…
Lifestyle
'KOSDAQ Promotion-Demotion System Overhaul Imminent'…All Eyes on Hugel, Inc., CLASSYS Inc., and Pharmaresearch
With the restructuring of the KOSDAQ market’s promotion-demotion system imminent, interest is growing in which companies will be included in the so-called “Premier League” (Premium Group), which will …
Lifestyle
ADBIOTECH Co.,Ltd. Soars on Rights Offering and Corporate Restructuring… Prestige Rises on CDMO Expectations [Bio Spotlight]
On the 25th, the domestic pharmaceutical sector showed a generally weak performance. The pharmaceutical sector index fell 0.45% from the previous day. Out of a total of 160 stocks, 34 rose, 13 remaine…
Lifestyle
[BioUSA] 100억 in Sales Thanks to Genomic Technology… The Competitive Edge of InnoCras, Backed by Samsung, HYUNDAI BIOSCIENCE CO., LTD., KOLON CORPORATION, and Big Pharma
There is an unlisted biotech venture in which #Samsung, #HYUNDAI BIOSCIENCE CO., LTD., and KOLON CORPORATION(002020)have invested, and which has signed supply contracts with global Big Pharma companie…
Technology
Yuhan Corporation and HK inno.N Corporation Break Through Generic Drug Limitations and Improve Business Structure [Bio in Numbers ②]
Among domestic pharmaceutical companies, those that consistently prove their worth through solid financial results (numbers) are drawing attention. In the past, pharmaceutical companies were stuck in …